| 123Jump Rating: |
|
Underwriters: |
Pacific Growth Equities, Inc.
|
| |
|
|
Lazard Capital Markets LLC
|
| Status: |
Filed |
|
|
| |
| Address: |
3400 W. Bayshore Road,
|
FiledDate: |
01/09/2008 |
| |
Palo Alto,
|
|
|
| |
CA 94303
|
Filed Price Range ($): |
|
| |
|
|
|
| Telephone: |
650-320-3800 |
Filed Offer Amount ($ Million): |
$86.00 |
| |
|
|
|
| Fax: |
|
Shares Offered (Millions): |
|
| |
|
|
|
| Websites: |
www.bayhilltherapeutics.com |
Shares Outstanding (Millions): |
|
| |
|
|
|
| Management: |
Mark Schwartz, CEO
|
IPO Date: |
|
| |
|
|
|
| |
|
Final Offer Price ($): |
$0.00 |
| |
|
|
|
| Industry: |
Healthcare |
Final Offer Size (Millions of Shares): |
0.00 |
| |
|
|
|
| Employees: |
39 |
Final Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Competitors: |
Pharmaceutical companies
|
S-1 Forms: |
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
- Avoid 
- Value Gap 
- Short-Term Growth
- Long-Term Growth 
- Long-Term Value 
